Ranolazine
- Product NDC
- 69097-221
- 11-digit product format
- 690970221
- Labeler code
- 69097
- Product ID
- 69097-221_7141ddf2-9c11-4d86-a0b3-ec7fd7e035b0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranolazine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA211291
- Marketing category
- ANDA
- Marketing start
- 2019-05-28
- Marketing end
- 0000-00-00
- Substance
- RANOLAZINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-221-02 | 69097022102 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69097-221-02) | 2019-05-28 | 0000-00-00 | No | No | Current |
| 69097-221-03 | 69097022103 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69097-221-03) | 2019-05-28 | 0000-00-00 | No | No | Current |
| 69097-221-12 | 69097022112 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69097-221-12) | 2019-05-28 | 0000-00-00 | No | No | Current |